期刊文献+

肝纤维化的功能磁共振研究进展 被引量:4

Functional MR study of hepatic fibrosis
下载PDF
导出
摘要 肝纤维化的准确诊断和分期对于监测肝脏疾病的进展和疗效是非常重要的。肝活检是评估肝纤维化的金标准,然而,因其有创性不能被用作人群筛查和监测疾病进展及观察疗效。磁共振功能成像作为一种无创的评估肝纤维化的手段,而成为当前的研究热点。磁共振弹力成像对肝纤维化分期诊断的价值最大,能够对肝纤维化病变作出分期诊断,磁共振弥散加权成像效果次之。当前,多数磁共振功能成像包括弥散加权成像和波谱成像及灌注成像,能对中晚期肝纤维化或肝硬化作出准确诊断,对于轻中度肝纤维化的鉴别效果尚不肯定。 The accurate diagnosis and staging of hepatic fibrosis is crucial for treatment and prognosis of liver disease.The current gold standard is liver biopsy,but it cannot be used in population-based screening,and has well known drawbacks if used for monitoring of disease progression or treatment results.Functional MR,as a non-invasive method,is increasingly used in hepatic fibrosis and became the current hot spot.Most recently available functional MR imaging techniques including diffusion weighted imaging,perfusion weighted imaging and MR spectroscopy can detect cirrhosis or fibrosis reasonably accurately.However,to date only MR elastography has been able to stage fibrosis or diagnose mild disease.MR diffusion weighted appears next most promising.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2010年第2期207-214,共8页 Journal of Zhejiang University(Medical Sciences)
基金 传染病诊治国家重点实验室自主研究课题 浙江省卫生厅基金项目(2009A088)
关键词 肝硬化/诊断 磁共振成像/方法 功能磁共振 肝纤维化 综述[文献类型] Liver cirrhosis/diag Magnetic resonance imaging/methods Functional MR Hepatic fibrosis Review [Publication type]
  • 相关文献

参考文献59

  • 1FOSTER G R, GOLDIN R D, MAIN J, et al.Management of chronic hepatitis C:clinical audit of biopsy based management algorithm [ J ]. BMJ, 1997,315(7106) :453-458.
  • 2POYNARD T, RATZIU V, BENHAMOU Y, et al. Natural history of HCV infection [ J ]. Baillieres Best Pratt Res Clin Gastroenterol,2000,14 (2) : 211-228.
  • 3BATTS K P, LUDWIG J. Chronic hepatitis: an update on terminology and reporting [ J ]. Am J Surg Pathol, 1995,19 (12) : 1409-1417.
  • 4CASTERA L. Non-invasive diagnosis of steatosis and fibrosis [ J ]. Diabetes & Metabolism, 2008, 34(6 pt 2) :674-679.
  • 5POYNARD T, MCHUTCHISON J, DAVIS G L, et al. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C [ J ]. Hepatology, 2000,32 ( 5 ) : 1131- 1137.
  • 6SHIRATORI Y, IMAZEKI F, MORIYAMA M, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy [ J ]. Ann Intern Med,2000,132 (7) :517-524.
  • 7DIXON J B, BHATHAL P S, HUGHES N R, O' Brien PE. Nonalcoholic fatty liver disease : improvement in liver histological analysis with weight loss [ J ]. Hepatology, 2004,39 ( 96 ) : 1647- 1654.
  • 8FARCI P, ROSKAMS T, CHESSA L, et al. Long- term benefit of interferon alpha therapy of chronic hepatitis D:regression of advanced hepatic fibrosis [ J ]. Gastroenterology, 2004,126 ( 7 ) : 1740-1749.
  • 9FOWELL A J, IREDALE J P. Emerging therapies for liver fibrosis [ J ]. Dig Dis, 2006, 24 ( 1-2 ) : 174-183.
  • 10FRIEDMAN S L, BANSAI M B. Reversal of hepatic fibrois - fact of fantasy [ J ] ? Hepatology, 2006,43 (2 suppl 1 ) : S82-S88.

二级参考文献17

  • 1Nicholson J.K,Lindon J.C,Holmes E..Xenobiotica[J],1999,29(11):1181-1189
  • 2Griffin J.L..Current Opinion in Chemical Biology[J],2003,7:648-654
  • 3Constantinou M.A,Papakonatantinou E,Benaki D.et al..Analytica Chimica Acta[J],2004,511:303-312
  • 4Cheng L.L,Lean C,Bogdanova A.et al..Magn.Reson.Med.[J],1996,36:653-658
  • 5Millis K,Maas W,Cory D.et al..Magn.Reson.Med.[J],1997,38:399-403
  • 6Moka D,Vorreuther R,Schicha H.et al..Anal.Commun.[J],1997,34:107-109
  • 7Lindon J.C,Holmes E,Nicholson J.K..Progress in Nuclear Magnetic Resonance Spectroscopy[J],2001,39:1-40
  • 8Waters N.J,Holmes E,Waterfield C.J.et al..Biochemical Pharmacology[J],2002,64:67-77
  • 9Wang Yu-lan,Bollard M.E,Keun H.et al..Analytical Biochemistry[J],2003,323:26-32
  • 10Joseph G,Gowrl C..The International Journal of Biochemistry & Cell Biology[J],1996,28(3):353-361

共引文献1

同被引文献52

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部